IPO Market Enters Fourth Quarter with the Wind at its Back The US IPO market saw 29 IPOs raise $4.1 billion in the third quarter, a drop from the prior year period. Small-cap health care companies, mostly biotechs, made up almost half of all...read more
In another strong week for IPOs, six companies combined to raise $1.2 billion. Five of the six realized positive first-day returns, and three finished their first day up more than 40%. This active week brought the total of 2017 IPOs to 106, passing the total for...read more
Nightstar Therapeutics, a UK biotech developing gene therapies for rare retinal diseases, raised $75 million by offering 5.4 million shares at $14, at the midpoint of $13 to $15 targeted range. Nightstar Therapeutics plans to list on the Nasdaq under the symbol...read more
Renaissance Capital's 3Q17 US IPO Market Review
IPO Market Enters Fourth Quarter with the Wind at its Back The US IPO market saw 29 IPOs raise $4.1 billion in the third quarter, a drop from the prior year period. Small-cap health care companies, mostly biotechs, made up almost half of all...read more
US IPO Weekly Recap: Roku streams ahead in week of 6 IPOs
In another strong week for IPOs, six companies combined to raise $1.2 billion. Five of the six realized positive first-day returns, and three finished their first day up more than 40%. This active week brought the total of 2017 IPOs to 106, passing the total for...read more
UK gene therapy company Nightstar Therapeutics prices IPO at $14 midpoint
Nightstar Therapeutics, a UK biotech developing gene therapies for rare retinal diseases, raised $75 million by offering 5.4 million shares at $14, at the midpoint of $13 to $15 targeted range. Nightstar Therapeutics plans to list on the Nasdaq under the symbol...read more
US IPO Week Ahead: Set-top boxes top off the 3Q17 as Roku headlines 7-IPO week
The IPO market will close out the third quarter with another active week: Seven deals are expected to raise $1.3 billion. High-growth TV streaming...read more